JAMIE GRANGE: Open Payments
NPI 1528438140 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 25 payments from 8 companies in 2025. Trend: 2023 $162 · 2024 $317 · 2025 $537
Food & beverage: $446Education: $91
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $174 |
| Amgen Inc. | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $91 |
| ABBVIE INC. | 3 | $58 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: DUPIXENT, TAVNEOS, UBRELVY, QULIPTA, TRELEGY ELLIPTA, TEZSPIRE, LIBTAYO, FASENRA.
Industry payments across UT — which companies pay providers there.
